17 April - Dr Stewart Washer

Stewart has 25 years of CEO and ASX Board experience in medical technology and agri-biotech companies.

He is currently the Chairman of Rumin8 Pty Ltd, developing methane reducing technology for cattle funded by Bill Gates’ Breakthrough Energy and Andrew Forest’s Harvest Road funds, Director of Botanix Ltd (ASX:BOT), with a dermatology pipeline in Australia and the USA.

He was recently Chairman of Emyria Ltd (ASX:EMD), creating new cannabinoid and MDMA based drugs for mental health and other diseases, was founding Chairman of Orthocell Ltd (ASX:OCC), a regenerative medicine company dedicated to providing innovative treatments for people suffering from nerve and tendon injuries, was founding Chairman of Cynata Therapeutics Ltd (ASX:CYP) who are developing global stem cell therapies in late stage clinical trials.

Stewart was previously the CEO of Calzada Ltd (ASX:PNV), the founding CEO of Phylogica Ltd (ASX:PYC) and before this, he was CEO of Celentis and managed the commercialisation of research from AgResearch in New Zealand with 650 Scientists and $130m revenues. This included a number of nutraceutical products. He was also a founder of a NZ$120m New Zealand based life science fund and Venture Partner with the Swiss based Inventages Nestlé Fund. He was an Investment Director with Bioscience Managers.

Stewart has held a number of Board positions in the past including Founding Chairman of Hatchtech Pty Ltd that sold in 2015 for A$279m, Director of iCeutica Pty Ltd that sold to a US Pharma and a Director of AusBiotech Ltd, the Federal industry body. He was also a Senator with Murdoch University.

$35 per person